In 2024, the total import and export value of the Beijing Tianzhu Comprehensive Bonded Zone reached CNY 123.49 billion, with the pharmaceutical industry contributing CNY 106.934 billion, marking a 6.39 percent year-on-year growth. The data indicates that the pharmaceutical industry continued staying ahead of other airport economy sectors, with remarkable achievements observed in the development of a pioneering zone for rare disease drug supply.

The Beijing Tianzhu Comprehensive Bonded Zone has formed a layout of the entire industry chains for the pharmaceutical and healthcare sectors highlighted by the cross-border pharmaceutical trade. In 2024, the cross-border pharmaceutical trade industry in the zone showed high growth momentum. Among China's top four pharmaceutical distribution companies, Shanghai Pharma (SPH)[BESTEASY1]  and China National Pharmaceutical Group (Sinopharm)[BESTEASY2]  have both opened warehouses and trade entities in the zone. Meanwhile, international pharmaceutical giants Merck and Johnson & Johnson have also set up trading operations, while other international players such as Pfizer, Novartis, Bayer, and MSD have also started pharmaceutical distribution operations in the area.

(Source: Integrated Media Center of Shunyi District)